Saturday, July 11, 2026

Drug profile · INN

fk506

fk506 is a fk506-binding protein 1a inhibitor.

NMPA: clinical trials
Patents linked 0
Pipeline programs 0
News articles 0
Drug details — fk506
Class
Route
Patents
0
Programs
0
Data quality
0.70

Quick answer

fk506 is a fk506-binding protein 1a inhibitor.

Key facts

INN fk506
Mechanism FK506-binding protein 1A inhibitor
Target Peptidyl-prolyl cis-trans isomerase FKBP1A

Mechanism of action

FK506-binding protein 1A inhibitor

Primary target: Peptidyl-prolyl cis-trans isomerase FKBP1A

Approval history

Authority Status Date
NMPA clinical trials

Related & competitor drugs

  1. everolimus Antineoplastic and immunomodulating agents (L01)
  2. sirolimus Antineoplastic and immunomodulating agents (L04)
  3. tacrolimus Dermatologicals (D11)
  4. pimecrolimus FK506-binding protein 1A inhibitor
  5. temsirolimus Antineoplastic and immunomodulating agents (L01)
  6. rad001 FK506-binding protein 1A inhibitor

Frequently asked questions

What is fk506?

fk506 is a fk506-binding protein 1a inhibitor.